Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > NEWS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by SteadyHandsStanon May 28, 2017 9:23am
284 Views
Post# 26293255

NEWS

NEWS
  1.  
  2. SeinfeldJerry

    Da Mc

    $CXRX $CXR.CA AMCo president Graeme Duncan sold all of his shares after Q1 earnings. Bearish
    SYMBOL CURRENT PRICE SINCE MESSAGED  
    CXRX
    Concordia Healthcare
    1.29
    0.00 (0.00%)
     
     
    TRADE CXRX NOW
     
  3.  
    May. 27 at 4:13 AM
    manning3
    @SeinfeldJerry This news is a real confidence breaker. He now doesn't own ANY shares. Bearish
     

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities